8:00 - 9:00am

Registration and Vendor Exhibits (with coffee and refreshments)

9:00 - 9:05am

Welcome Remarks

Wei Dong, M.D., Ph.D. (CABS President-Elect)

9:05 - 9:15am

State of the Society

Shichang Miao, Ph.D. (CABS President)

Session I: Global Discovery and Development

Co-chairs: Charlene Liao , Ph.D., Cheni Kwok , Ph.D., CLP

9:15 - 9:40am

Small Molecule Drug Discovery in the Modern World

Michael D. Varney, Ph.D, Senior Vice President, Small Molecule Drug Discovery, Genentech

9:40 - 10:05am

New Medicines for the Developing World

Richard Chin, M.D., CEO, Institute for OneWorld Health

10:05 - 10:30am

Singapore: Biopolis of Asia

Ih-Ming Chan, Center Director, Americas , Singapore Economic Development Board

10:30 - 10:55am

Opportunities and Challenges in Global Drug Development – Including China as a Key Country

Michael Doherty, Global Head of Regulatory Affairs, Hoffmann-La Roche Ltd and Genentech

10:55 - 11:15am

Break, Networking & Vendor Exhibits

Session II: Advances in Neuroscience

Co-chairs: Zhonghua Pei , Ph.D.,  Hua Tu, Ph.D.

11:15 - 11:40am

Mapping Olfaction in the Fly and Mouse Brain

Liqun Luo, Ph.D., Professor, HHMI Investigator, Stanford University

11:40 - 12:05pm

Neuroscience at Genentech  

Morgan Sheng, MBBS, Ph.D., Vice President of Neuroscience, Genentech

12:05 - 12:20pm

Diamond Sponsor Presentation

Suzhou-Nantong Science and Technology Park

12:20 - 1:20pm

Lunch, Networking and Vendor Exhibits

Session III: Promising Pipelines and Technologies 

Co-chairs: Shichang Miao, Ph.D., Leping Li , Ph.D.  

1:20 - 1:45pm

Expanding Access to Patients in Need Around the World

Gregg H. Alton, J.D., Executive Vice President, Corporate and Medical Affairs, Gilead Sciences

1:45 - 2:10pm

Chemkines and Chemokine Receptors: A Rich Area for New Opportunities in Drug Discovery

Thomas J. Schall, Ph.D., President and CEO, ChemoCentryx

2:10 - 2:35pm

Molecular Motors and Beyond: Novel Targets for Small Molecule Drug Discovery

Bradley P. Morgan, Ph.D., Vice President of Chemistry, Cytokinetics

2:35 - 3:00pm

Unlocking the Power of RNA Biomarkers for Personalized Medicine

Yuling Luo, Ph.D., President and CEO, Advanced Cell Diagnostics

3:00 - 3:15pm

Platinum Sponsor Presentation

Pharmaron: A Fully Integrated CRO from Drug Discovery to IND Filing

Boliang Lou, Ph.D., Chairman and CEO, Pharmaron

3:15 - 3:35pm

Break, Networking & Vendor Exhibits

Session IV: Investment and Business Opportunities in China

Co-chairs: Connie Sun, Ph.D., Janet Xiao, Ph.D., J.D. 

3:35 - 3:55pm

Keys for Life Sciences Investing in China : What You Need to Know

Charles Comey, Managing Partner, Morrison Foerster’s Shanghai Office  

3:55 - 4:15pm

Enhancing International Competence of Chinese Biotech Enterprise by Promoting International Cooperation

Bing Zeng, Vice President of Sino-Pharm, and Sino-PHRDA Delegation Leader

4:15 - 4:35pm

China Drug Discovery Landscape Overview

Helen Chen, Ph.D., Director and Partner, Head of China Life Sciences, L.E.K Consulting, Shanghai

4:35 - 4:55pm

New Drug R&D “in China , for Global”

Dajun Yang, MD, Ph.D., President and CEO, Ascentage Pharma Group Corp.

Gold Sponsors’ Presentations

Co-chairs: Titan Gu, Ph.D.,   Zhen hai Shen, Ph.D., MBA

4:55 - 5:30pm

Rules Based Medicine                          Wuxi Apptec

Optivia/Primax                                     Sundia

Tianjin Free Port Trade Administrative Committee

5:30 - 6:00pm

Break, Networking & Vendor Exhibits

Evening Session: The Pharmaceutical Industry in China : the Current and the Future

Co-organized by China Pharmaceutical Research and Development Association (Sino-PHRDA)

Co-chairs: Wentao Zhang, Ph.D., Janet Xiao, Ph.D.

6:00 - 7:00pm

Dinner Served

6:30 - 6:40pm

Welcome Remarks

Shichang Miao, Ph.D., CABS President

6:40 - 9:00pm

Presentations from the Sino-PHRDA Delegation

Healthcare Reform and Opportunities for the Pharmaceutical Industry in China

Ruilin Song,  Executive President, China Pharmaceutical Research and Development Association

宋瑞霖,  中国医药工业科研开发促进会  执行会长

Development of Antibiotics in China

Baxian Yi, General manager, Sichuan Industrial Institute of Antibiotics

易八贤, 中国医药集团总公司四川抗菌素工业研究所 所长

Development Status and Trends of  the Biopharmaceutical Industry of Shanghai

Shaoxiong Chen, Secretary General, Shanghai Biopharmaceutical Industry Association

陈少雄, 上海市生物医药行业协会副会长兼秘书长

Kelun: A Rapidly-developing Pharmaceutical Company

Long Liang, President, Sichuan Kelun Pharmaceutical Research Ltd.

梁隆, 四川科伦药物研究有限公司总经理

Biolake and Central China 's Biotech Development

Wuhan BioLake (武汉光谷生物城)

Overview of LUYE Pharma and Yantai Biotech Research Park-BiOasis

Youxin Li, Executive Vice-President, Research and Development, Luye pharma Group

李又欣, 烟台绿叶集团副总裁

The Forefront of the Global Cancer Industry Development

Ruihua Jiang, Vice President, Zhendong Pharmaceutical Company Ltd.

蒋瑞华, 山西振东制药股份有限公司副总经理

9:00 - 9:20pm

Panel Discussions

9:20pm

Adjourned